Shuttle Pharmaceuticals Inc (SHPH) Stock Analysis

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

• Price: $1.09
• Market Cap: $3.51M
• EPS: $-3.42
• 52-Week High: $15.53
• 52-Week Low: $1.00

Market Sentiment

Shuttle Pharmaceuticals Inc currently has a Neutral sentiment score of 0.02.

About Shuttle Pharmaceuticals Inc

Shuttle Pharmaceuticals Holdings, Inc. is a biotechnology company based in Rockville, Maryland, specializing in the discovery and development of innovative therapeutic solutions that enhance the effectiveness of radiation therapy in cancer treatment. Through its subsidiary, Shuttle Pharmaceuticals, Inc., the company is dedicated to advancing its proprietary drug candidates designed to sensitize tumors to radiation, thereby improving patient outcomes. With a robust pipeline and a commitment to...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Shuttle Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does SHPH pay dividends?

Shuttle Pharmaceuticals Inc (SHPH) does not currently pay a regular dividend.

What is SHPH's market cap?

Shuttle Pharmaceuticals Inc (SHPH) has a market capitalization of $3.51M with a current stock price of $1.09.